Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7536386rdf:typepubmed:Citationlld:pubmed
pubmed-article:7536386lifeskim:mentionsumls-concept:C1135918lld:lifeskim
pubmed-article:7536386lifeskim:mentionsumls-concept:C0205042lld:lifeskim
pubmed-article:7536386lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:7536386lifeskim:mentionsumls-concept:C0178702lld:lifeskim
pubmed-article:7536386lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:7536386lifeskim:mentionsumls-concept:C1334043lld:lifeskim
pubmed-article:7536386lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:7536386pubmed:dateCreated1995-5-18lld:pubmed
pubmed-article:7536386pubmed:abstractTextIn addition to inhibition of platelet function, prostacyclin and its stable analogues are reported to attenuate vascular smooth muscle cell proliferation. However, desensitization of prostacyclin responsiveness is a known phenomenon in platelets. In this study we investigated the time-dependent effects of the prostacyclin-mimetic iloprost and of PGE1, respectively, on PDGF-induced proliferation of cultured coronary artery smooth muscle cells. Proliferation, assessed by [3H]thymidine incorporation was markedly inhibited by coincubation with iloprost (100 nM) and PGE1 (100 nM) for 4 h. In contrast, addition of iloprost (100 nM) for 24 h did not decrease smooth muscle cell proliferation, whereas inhibition by PGE1 or by forskolin was not diminished. These results suggest a homologous desensitization of anti-mitogenic effects of iloprost in coronary artery smooth muscle cells, probably at receptor-level.lld:pubmed
pubmed-article:7536386pubmed:languageenglld:pubmed
pubmed-article:7536386pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:citationSubsetIMlld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7536386pubmed:statusMEDLINElld:pubmed
pubmed-article:7536386pubmed:issn0379-0363lld:pubmed
pubmed-article:7536386pubmed:authorpubmed-author:SchrörKKlld:pubmed
pubmed-article:7536386pubmed:authorpubmed-author:ZuckerT PTPlld:pubmed
pubmed-article:7536386pubmed:authorpubmed-author:GrosserTTlld:pubmed
pubmed-article:7536386pubmed:authorpubmed-author:BönischDDlld:pubmed
pubmed-article:7536386pubmed:issnTypePrintlld:pubmed
pubmed-article:7536386pubmed:volume45lld:pubmed
pubmed-article:7536386pubmed:ownerNLMlld:pubmed
pubmed-article:7536386pubmed:authorsCompleteYlld:pubmed
pubmed-article:7536386pubmed:pagination85-91lld:pubmed
pubmed-article:7536386pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:meshHeadingpubmed-meshheading:7536386-...lld:pubmed
pubmed-article:7536386pubmed:year1995lld:pubmed
pubmed-article:7536386pubmed:articleTitleIloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization.lld:pubmed
pubmed-article:7536386pubmed:affiliationInstitute für Pharmakologie, Heinrich-Heine-Universität Düsseldorf, FRG.lld:pubmed
pubmed-article:7536386pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7536386pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7536386lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7536386lld:pubmed